LifeStance Health Group, Inc. (LFST)
NASDAQ: LFST · IEX Real-Time Price · USD
6.02
+0.07 (1.18%)
At close: Mar 27, 2024, 4:00 PM
6.07
+0.05 (0.83%)
Pre-market: Mar 28, 2024, 7:00 AM EDT

LifeStance Health Group Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212019
Revenue
1,056859.54667.51212.52
Revenue Growth (YoY)
22.82%28.77%214.10%-
Cost of Revenue
753.57622.53466150.12
Gross Profit
302.1237.02201.5162.4
Selling, General & Admin
410.79377.99433.7341.06
Other Operating Expenses
80.4469.254.146.1
Operating Expenses
491.23447.19487.8647.16
Operating Income
-189.13-210.17-286.3515.24
Interest Expense / Income
21.2219.9338.915.41
Other Expense / Income
-3.772.6344.591.96
Pretax Income
-206.58-232.73-369.867.88
Income Tax
-20.32-17.17-25.912.21
Net Income
-186.26-215.56-343.955.67
Preferred Dividends
00064.57
Net Income Common
-186.26-215.56-343.95-58.9
Shares Outstanding (Basic)
367355328-
Shares Outstanding (Diluted)
367355328-
Shares Change
3.43%8.47%--
EPS (Basic)
-0.51-0.61-1.05-
EPS (Diluted)
-0.51-0.61-1.05-
Free Cash Flow
-57.4-26.47-85.072.73
Free Cash Flow Per Share
-0.16-0.07-0.26-
Gross Margin
28.62%27.57%30.19%29.36%
Operating Margin
-17.92%-24.45%-42.90%7.17%
Profit Margin
-17.64%-25.08%-51.53%-27.72%
Free Cash Flow Margin
-5.44%-3.08%-12.74%1.29%
Effective Tax Rate
---28.01%
EBITDA
-64.94-105.44-276.8119.38
EBITDA Margin
-6.15%-12.27%-41.47%9.12%
Depreciation & Amortization
120.42107.3654.146.1
EBIT
-185.36-212.8-330.9413.28
EBIT Margin
-17.56%-24.76%-49.58%6.25%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).